Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

2.2K
The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

321
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
321
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

57
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
57
Cancer Survival Analysis01:21

Cancer Survival Analysis

821
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
821
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

78
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
78

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Catalyzing Health AI by Fixing Payment Systems.

NEJM AI·2026
Same author

Bridging the Gap: Consensus-Based Considerations for AI Usefulness in Healthcare.

The American journal of bioethics : AJOB·2026
Same author

Principles to guide clinical AI readiness and move from benchmarks to real-world evaluation.

Nature medicine·2026
Same author

AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence.

JAMA·2025
Same author

Lessons from Henrietta Lacks inform a transparency framework to catalyze generative artificial intelligence in medicine.

NPJ digital medicine·2025
Same author

Optimal Vasopressin Initiation in Septic Shock: The OVISS Reinforcement Learning Study.

JAMA·2025

Related Experiment Video

Updated: Mar 24, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

A Probabilistic Graphical Model for Individualizing Prognosis in Chronic, Complex Diseases.

Peter Schulam1, Suchi Saria2

  • 1Dept. of Computer Science, Johns Hopkins University, Baltimore, MD.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|March 10, 2016
PubMed
Summary

This study introduces a new probabilistic model to predict disease progression by identifying patient subtypes. The model improves individualized prognoses for chronic diseases like scleroderma, enhancing lung function predictions.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Related Experiment Videos

Last Updated: Mar 24, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Area of Science:

  • Computational biology
  • Medical informatics
  • Disease modeling

Background:

  • Accurate prognoses for chronic, complex diseases are difficult due to individual variability.
  • Disease subtypes, sharing similar progression patterns, are often proposed but challenging to identify.
  • Existing methods lack robust individualization for predicting disease trajectories.

Purpose of the Study:

  • To develop a probabilistic model for individualizing disease trajectory prognoses using subtypes.
  • To automatically learn disease subtypes from data.
  • To dynamically update predictions using static and time-varying markers.

Main Methods:

  • Developed a probabilistic model leveraging the concept of subtypes.
  • Employed machine learning for automatic subtype discovery from data.
  • Integrated static and time-varying patient markers for dynamic prediction updates.

Main Results:

  • Successfully learned disease subtypes from observational data.
  • Demonstrated improved prediction of lung function trajectories in scleroderma patients.
  • Showcased enhanced individualized disease prognosis capabilities.

Conclusions:

  • The developed probabilistic model effectively individualizes prognoses for complex chronic diseases.
  • Automatic subtype identification and dynamic marker integration improve predictive accuracy.
  • This approach offers a significant advancement in predicting disease trajectories, particularly in autoimmune conditions like scleroderma.